Influential factors in the adherence and abandonment of preventive therapy for latent tuberculosis infection in patients with HIV

被引：0
|
作者：
Bedoya Serna, Beatriz Eugenia [1 ]
机构：
[1] Corp Invest Biol, Medellin, Colombia
来源：
ARCHIVOS DE MEDICINA | 2019年 / 19卷 / 01期
关键词：
HIV; latent tuberculosis; chemoprevention; FAILURE; PREDICTORS; ADULTS; TRIAL;
D O I：
10.30554/archmed.19.1.2791.2019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective: to describe the factors that influence the lack of adherence to the treatment of the latent tuberculosis infection. Materials and methods: retrospective and descriptive study in people living with the human immunodeficiency virus treated in a health institution of Medellin, Colombia. Results: 45% of patients presented adherence problems such as interruptions less than 30 days or loss of follow-up, the statistical significance (p < 0.05) was presented in the variables of adverse effects and adherence to antiretroviral treatment. Conclusion: adverse effects to treatment and adherence to antiretroviral therapy are associated with problems of adherence to preventive treatment of latent tuberculosis infection.
引用
收藏
页数：12
相关论文
共 50 条
  • [11] Preventive treatment for latent tuberculosis infection
    Agca, Filiz Duyar
    Ceyhan, Onur Aksu
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [12] Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy
    Matteelli, A
    Casalini, C
    Raviglione, MC
    El-Hamad, I
    Scolari, C
    Bombana, E
    Bugiani, M
    Caputo, M
    Scarcella, C
    Carosi, G
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (05) : 1653 - 1655
  • [13] Latent Tuberculosis and HIV Infection
    Bares, Sara H.
    Swindells, Susan
    [J]. CURRENT INFECTIOUS DISEASE REPORTS, 2020, 22 (07)
  • [14] Latent Tuberculosis and HIV Infection
    Sara H. Bares
    Susan Swindells
    [J]. Current Infectious Disease Reports, 2020, 22
  • [15] PREVENTIVE THERAPY FOR TUBERCULOSIS IN HIV-INFECTION - THE PROMISE AND THE REALITY
    OBRIEN, RJ
    PERRIENS, JH
    [J]. AIDS, 1995, 9 (07) : 665 - 673
  • [16] Trials of Tuberculosis-Preventive Therapy in People with HIV Infection
    Swindells, Susan
    Hughes, Michael
    Chaisson, Richard E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (02) : 304 - 305
  • [17] Twice weekly tuberculosis preventive therapy in HIV infection in Zambia
    Mwinga, A
    Hosp, M
    Godfrey-Faussett, P
    Quigley, M
    Mwaba, P
    Mugala, BN
    Nyirenda, O
    Luo, N
    Pobee, J
    Elliott, AM
    McAdam, KPWJ
    Porter, JDH
    [J]. AIDS, 1998, 12 (18) : 2447 - 2457
  • [18] Latent tuberculosis in patients with recently diagnosed HIV infection
    Soto, L.
    Guevara, R. N.
    Landaeta, M. E.
    [J]. HIV MEDICINE, 2023, 24 : 328 - 328
  • [19] In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection
    Menzies, D
    Dion, MJ
    Francis, D
    Parisien, I
    Rocher, I
    Mannix, S
    Schwartzman, K
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (12) : 1343 - 1348
  • [20] Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS
    Gutierrez, E. B.
    Gomes, V.
    Picone, C. M.
    Suga, H.
    Atomiya, A. N.
    [J]. HIV MEDICINE, 2009, 10 (09) : 564 - 572
12345